Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-20

FDA Approved: PRIMIDONE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Primidone by Oxford Pharmaceuticals, LLC under an ANDA for this generic antiseizure medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMIDONE (Primidone)

Snippet

SUPPL AP for PRIMIDONE (PRIMIDONE)